Streetbeat News

Products Services

CLNN

Clene, Inc. (NASDAQ:CLNN) has been awarded a grant from the National Multiple Sclerosis Society (NMSS) to advance the development of its lead drug candidate, CNM-Au8, in non-active progressive multiple sclerosis. The grant will fund Cohort 2 of the REPAIR-MS Phase 2 clinical study, which aims to determine the effects of CNM-Au8 on brain energy metabolites in patients with non-active progressive MS.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 12:20 pm

AAPL

BKYI

BIO-key has unveiled new PortalGuard feature enhancements, including support for MacOS multi-factor authentication for enterprise users. This update aims to improve security and user experience for MacOS users.

Portfolio Pulse from Benzinga Newsdesk

May 25, 2023 | 12:20 pm

NUTX

Nutex Health (NASDAQ:NUTX) has announced a strategic partnership with MeMed to adopt the MeMed BV test across its network of 19 sites. The FDA-cleared technology distinguishes viral from bacterial infections in 15 minutes, helping physicians make better informed antibiotic treatment decisions.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 12:19 pm

MNMD

MindMed has published a report by Greenleaf Health, led by former senior FDA officials, validating the company's MM-120 drug development strategy. The report supports MindMed's ongoing Phase 2b trial for MM-120 in patients with generalized anxiety disorder and highlights the risks of skipping Phase 2.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 12:18 pm

BGNE

BMY

MRTX

Mirati Therapeutics' SAPPHIRE study, evaluating sitravatinib in combination with Bristol-Myers Squibb's Opdivo for advanced non-squamous non-small cell lung cancer, failed to meet its primary endpoint of overall survival. Mirati's stock price fell 6.48% in premarket trading.

Portfolio Pulse from Vandana Singh

May 25, 2023 | 12:18 pm

SQNS

Sequans Communications (SQNS) announced that Geotab Inc., a global leader in connected transportation solutions, has selected Sequans' Calliope 2 Cat 1bis technology as part of its product strategy. The technology offers optimized connectivity, improved performance, and reduced power consumption.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 12:16 pm

OTRK

Ontrak, Inc. (NASDAQ:OTRK) has achieved NCQA certification as a Credentials Verification Organization (CVO), reinforcing its commitment to quality assurance in healthcare. This certification validates Ontrak's high standards of quality and compliance in its healthcare solutions, enabling customers to meet their accreditation goals.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 12:16 pm

ONTX

Onconova Therapeutics has announced the dosing of the first participant in an investigator-sponsored Phase 2 trial of oral rigosertib plus pembrolizumab for metastatic melanoma patients who have progressed on prior PD-1/L1 inhibitor therapy. The trial aims to explore the potential of rigosertib to enhance the efficacy of immune checkpoint blockade in metastatic melanoma.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 12:15 pm

ANNX

Annexon Inc announced mixed topline results from its ARCHER Phase 2 trial of ANX007 in patients with geographic atrophy (GA). The drug was not statistically significant compared to pooled sham at 12 months, but showed a reduction in the risk of 15-letter loss. ANX007 was well-tolerated, and the company plans to focus on a late-stage study.

Portfolio Pulse from Vandana Singh

May 25, 2023 | 12:15 pm

CAT

LASE

Laser Photonics Corporation (LASE) has received a second order from Caterpillar Inc. (CAT) for its MarkStar Pro Handheld Laser Marker, which will be used for inventory management at Caterpillar's Peoria, Illinois facility.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 12:12 pm